LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article ; Online: Serum amyloid A impairs the antiinflammatory properties of HDL.

    Han, Chang Yeop / Tang, Chongren / Guevara, Myriam E / Wei, Hao / Wietecha, Tomasz / Shao, Baohai / Subramanian, Savitha / Omer, Mohamed / Wang, Shari / O'Brien, Kevin D / Marcovina, Santica M / Wight, Thomas N / Vaisar, Tomas / de Beer, Maria C / de Beer, Frederick C / Osborne, William R / Elkon, Keith B / Chait, Alan

    The Journal of clinical investigation

    2016  Volume 126, Issue 1, Page(s) 266–281

    Abstract: ... of antiinflammatory and cholesterol efflux properties in adipocytes. Conversely, incorporation of SAA into HDL ... preparations reduced antiinflammatory properties but not to the same extent as HDL from AgNO3-injected mice ... however, the effect of the inflammatory state on the functional properties of HDL on adipocytes is unknown. Here ...

    Abstract HDL from healthy humans and lean mice inhibits palmitate-induced adipocyte inflammation; however, the effect of the inflammatory state on the functional properties of HDL on adipocytes is unknown. Here, we found that HDL from mice injected with AgNO3 fails to inhibit palmitate-induced inflammation and reduces cholesterol efflux from 3T3-L1 adipocytes. Moreover, HDL isolated from obese mice with moderate inflammation and humans with systemic lupus erythematosus had similar effects. Since serum amyloid A (SAA) concentrations in HDL increase with inflammation, we investigated whether elevated SAA is a causal factor in HDL dysfunction. HDL from AgNO3-injected mice lacking Saa1.1 and Saa2.1 exhibited a partial restoration of antiinflammatory and cholesterol efflux properties in adipocytes. Conversely, incorporation of SAA into HDL preparations reduced antiinflammatory properties but not to the same extent as HDL from AgNO3-injected mice. SAA-enriched HDL colocalized with cell surface-associated extracellular matrix (ECM) of adipocytes, suggesting impaired access to the plasma membrane. Enzymatic digestion of proteoglycans in the ECM restored the ability of SAA-containing HDL to inhibit palmitate-induced inflammation and cholesterol efflux. Collectively, these findings indicate that inflammation results in a loss of the antiinflammatory properties of HDL on adipocytes, which appears to partially result from the SAA component of HDL binding to cell-surface proteoglycans, thereby preventing access of HDL to the plasma membrane.
    MeSH term(s) 3T3-L1 Cells ; Adipocytes/metabolism ; Animals ; C-Reactive Protein/analysis ; Cholesterol/metabolism ; Humans ; Inflammation/prevention & control ; Lipoproteins, HDL/physiology ; Male ; Mice ; Mice, Inbred C57BL ; Reactive Oxygen Species/metabolism ; Serum Amyloid A Protein/physiology ; Silver Nitrate/pharmacology ; Toll-Like Receptor 4/physiology
    Chemical Substances Lipoproteins, HDL ; Reactive Oxygen Species ; Serum Amyloid A Protein ; Toll-Like Receptor 4 ; C-Reactive Protein (9007-41-4) ; Silver Nitrate (95IT3W8JZE) ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2016-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI83475
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Serum amyloid A impairs the antiinflammatory properties of HDL.

    Han, Chang Yeop / Tang, Chongren / Guevara, Myriam E / Wei, Hao / Wietecha, Tomasz / Shao, Baohai / Subramanian, Savitha / Omer, Mohamed / Wang, Shari / O'Brien, Kevin D / Marcovina, Santica M / Wight, Thomas N / Vaisar, Tomas / de Beer, Maria C / de Beer, Frederick C / Osborne, William R / Elkon, Keith B / Chait, Alan

    The Journal of clinical investigation

    2016  Volume 126, Issue 2, Page(s) 796

    Language English
    Publishing date 2016-02
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI86401
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Antiinflammatory properties of HDL.

    Barter, Philip J / Nicholls, Stephen / Rye, Kerry-Anne / Anantharamaiah, G M / Navab, Mohamad / Fogelman, Alan M

    Circulation research

    2004  Volume 95, Issue 8, Page(s) 764–772

    Abstract: ... antiinflammatory properties of HDL may be as important as its cholesterol efflux function in terms of protecting ... of foam cells in the artery wall. However, HDL has additional properties that may also be antiatherogenic ... properties. As a consequence, HDL has the capacity to inhibit the oxidative modification ...

    Abstract There are several well-documented functions of high-density lipoprotein (HDL) that may explain the ability of these lipoproteins to protect against atherosclerosis. The best recognized of these is the ability of HDL to promote the efflux of cholesterol from cells. This process may minimize the accumulation of foam cells in the artery wall. However, HDL has additional properties that may also be antiatherogenic. For example, HDL is an effective antioxidant. The major proteins of HDL, apoA-I and apoA-II, as well as other proteins such as paraoxonase that cotransport with HDL in plasma, are well-known to have antioxidant properties. As a consequence, HDL has the capacity to inhibit the oxidative modification of low-density lipoprotein (LDL) in a process that reduces the atherogenicity of these lipoproteins. HDL also possesses other antiinflammatory properties. By virtue of their ability to inhibit the expression of adhesion molecules in endothelial cells, they reduce the recruitment of blood monocytes into the artery wall. These antioxidant and antiinflammatory properties of HDL may be as important as its cholesterol efflux function in terms of protecting against the development of atherosclerosis.
    MeSH term(s) Arteriosclerosis/blood ; Arteriosclerosis/etiology ; Arteriosclerosis/prevention & control ; C-Reactive Protein/physiology ; Cell Adhesion Molecules/physiology ; Chemokines/antagonists & inhibitors ; Chemokines/physiology ; Cholesterol/metabolism ; Cholesterol, HDL/blood ; Endothelium, Vascular/metabolism ; Endothelium, Vascular/physiopathology ; Gene Expression Regulation ; Humans ; Inflammation/blood ; Inflammation/complications ; Lipoproteins, HDL/physiology ; Oxidation-Reduction ; Oxidative Stress ; Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors
    Chemical Substances Cell Adhesion Molecules ; Chemokines ; Cholesterol, HDL ; Lipoproteins, HDL ; C-Reactive Protein (9007-41-4) ; Cholesterol (97C5T2UQ7J) ; Phosphotransferases (Alcohol Group Acceptor) (EC 2.7.1.-) ; sphingosine kinase (EC 2.7.1.-)
    Language English
    Publishing date 2004-10-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/01.RES.0000146094.59640.13
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Serum amyloid A-containing HDL binds adipocyte-derived versican and macrophage-derived biglycan, reducing its antiinflammatory properties.

    Han, Chang Yeop / Kang, Inkyung / Omer, Mohamed / Wang, Shari / Wietecha, Tomasz / Wight, Thomas N / Chait, Alan

    JCI insight

    2020  Volume 5, Issue 20

    Abstract: ... the role of proteoglycans in determining the antiinflammatory properties of HDL. The distributions ... biglycan, thereby blunting HDL's antiinflammatory properties. ... by silencing these proteoglycans, which also restored the antiinflammatory property of SAA-enriched HDL despite ...

    Abstract The ability of HDL to inhibit inflammation in adipocytes and adipose tissue is reduced when HDL contains serum amyloid A (SAA) that is trapped by proteoglycans at the adipocyte surface. Because we recently found that the major extracellular matrix proteoglycan produced by hypertrophic adipocytes is versican, whereas activated adipose tissue macrophages produce mainly biglycan, we further investigated the role of proteoglycans in determining the antiinflammatory properties of HDL. The distributions of versican, biglycan, apolipoprotein A1 (the major apolipoprotein of HDL), and SAA were similar in adipose tissue from obese mice and obese human subjects. Colocalization of SAA-enriched HDL with versican and biglycan at the cell surface of adipocyte and peritoneal macrophages, respectively, was blocked by silencing these proteoglycans, which also restored the antiinflammatory property of SAA-enriched HDL despite the presence of SAA. Similar to adipocytes, normal HDL exerted its antiinflammatory function in macrophages by reducing lipid rafts, reactive oxygen species generation, and translocation of Toll-like receptor 4 and NADPH oxidase 2 into lipid rafts, effects that were not observed with SAA-enriched HDL. These findings imply that SAA present in HDL can be trapped by adipocyte-derived versican and macrophage-derived biglycan, thereby blunting HDL's antiinflammatory properties.
    MeSH term(s) Adipocytes/immunology ; Adipocytes/pathology ; Adult ; Animals ; Apolipoprotein A-I/genetics ; Apolipoprotein A-I/immunology ; Biglycan/antagonists & inhibitors ; Biglycan/genetics ; Biglycan/immunology ; Diet, High-Fat/adverse effects ; Female ; Gene Expression Regulation ; Humans ; Insulin Resistance/immunology ; Lipoproteins, HDL/genetics ; Lipoproteins, HDL/immunology ; Macrophages, Peritoneal/immunology ; Macrophages, Peritoneal/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Middle Aged ; Obesity/etiology ; Obesity/genetics ; Obesity/immunology ; Obesity/pathology ; Protein Binding ; Protein Transport ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; Reactive Oxygen Species/immunology ; Reactive Oxygen Species/metabolism ; Serum Amyloid A Protein/genetics ; Serum Amyloid A Protein/immunology ; Silver Nitrate/administration & dosage ; Toll-Like Receptor 4/genetics ; Toll-Like Receptor 4/immunology ; Versicans/antagonists & inhibitors ; Versicans/genetics ; Versicans/immunology
    Chemical Substances APOA1 protein, human ; Apolipoprotein A-I ; BGN protein, human ; Biglycan ; Lipoproteins, HDL ; RNA, Small Interfering ; Reactive Oxygen Species ; Serum Amyloid A Protein ; TLR4 protein, human ; Toll-Like Receptor 4 ; VCAN protein, human ; Versicans (126968-45-4) ; Silver Nitrate (95IT3W8JZE)
    Language English
    Publishing date 2020-09-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.142635
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Serum amyloid A–containing HDL binds adipocyte-derived versican and macrophage-derived biglycan, reducing its antiinflammatory properties

    Chang Yeop Han / Inkyung Kang / Mohamed Omer / Shari Wang / Tomasz Wietecha / Thomas N. Wight / Alan Chait

    JCI Insight, Vol 5, Iss

    2020  Volume 20

    Abstract: ... the role of proteoglycans in determining the antiinflammatory properties of HDL. The distributions ... biglycan, thereby blunting HDL’s antiinflammatory properties. ... by silencing these proteoglycans, which also restored the antiinflammatory property of SAA-enriched HDL despite ...

    Abstract The ability of HDL to inhibit inflammation in adipocytes and adipose tissue is reduced when HDL contains serum amyloid A (SAA) that is trapped by proteoglycans at the adipocyte surface. Because we recently found that the major extracellular matrix proteoglycan produced by hypertrophic adipocytes is versican, whereas activated adipose tissue macrophages produce mainly biglycan, we further investigated the role of proteoglycans in determining the antiinflammatory properties of HDL. The distributions of versican, biglycan, apolipoprotein A1 (the major apolipoprotein of HDL), and SAA were similar in adipose tissue from obese mice and obese human subjects. Colocalization of SAA-enriched HDL with versican and biglycan at the cell surface of adipocyte and peritoneal macrophages, respectively, was blocked by silencing these proteoglycans, which also restored the antiinflammatory property of SAA-enriched HDL despite the presence of SAA. Similar to adipocytes, normal HDL exerted its antiinflammatory function in macrophages by reducing lipid rafts, reactive oxygen species generation, and translocation of Toll-like receptor 4 and NADPH oxidase 2 into lipid rafts, effects that were not observed with SAA-enriched HDL. These findings imply that SAA present in HDL can be trapped by adipocyte-derived versican and macrophage-derived biglycan, thereby blunting HDL’s antiinflammatory properties.
    Keywords Cell biology ; Inflammation ; Medicine ; R
    Subject code 616
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher American Society for Clinical investigation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article: Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

    Vaisar, Tomas / Pennathur, Subramaniam / Green, Pattie S / Gharib, Sina A / Hoofnagle, Andrew N / Cheung, Marian C / Byun, Jaeman / Vuletic, Simona / Kassim, Sean / Singh, Pragya / Chea, Helen / Knopp, Robert H / Brunzell, John / Geary, Randolph / Chait, Alan / Zhao, Xue-Qiao / Elkon, Keith / Marcovina, Santica / Ridker, Paul /
    Oram, John F / Heinecke, Jay W

    The Journal of clinical investigation

    2007  Volume 117, Issue 3, Page(s) 746–756

    Abstract: ... that the protein cargo of HDL contributes to its antiinflammatory and antiatherogenic properties. ... from macrophage foam cells. However, other antiatherosclerotic properties of HDL are poorly understood. To test ... HDL lowers the risk for atherosclerotic cardiovascular disease by promoting cholesterol efflux ...

    Abstract HDL lowers the risk for atherosclerotic cardiovascular disease by promoting cholesterol efflux from macrophage foam cells. However, other antiatherosclerotic properties of HDL are poorly understood. To test the hypothesis that the lipoprotein carries proteins that might have novel cardioprotective activities, we used shotgun proteomics to investigate the composition of HDL isolated from healthy subjects and subjects with coronary artery disease (CAD). Unexpectedly, our analytical strategy identified multiple complement-regulatory proteins and a diverse array of distinct serpins with serine-type endopeptidase inhibitor activity. Many acute-phase response proteins were also detected, supporting the proposal that HDL is of central importance in inflammation. Mass spectrometry and biochemical analyses demonstrated that HDL3 from subjects with CAD was selectively enriched in apoE, raising the possibility that HDL carries a unique cargo of proteins in humans with clinically significant cardiovascular disease. Collectively, our observations suggest that HDL plays previously unsuspected roles in regulating the complement system and protecting tissue from proteolysis and that the protein cargo of HDL contributes to its antiinflammatory and antiatherogenic properties.
    MeSH term(s) Amino Acid Sequence ; Chromatography, Liquid ; Complement Activation ; Coronary Artery Disease/enzymology ; Coronary Artery Disease/immunology ; Humans ; Inflammation/metabolism ; Lipid Metabolism ; Lipoproteins, HDL/blood ; Lipoproteins, HDL/isolation & purification ; Lipoproteins, HDL/metabolism ; Mass Spectrometry ; Microscopy, Electron, Scanning ; Molecular Sequence Data ; Peptide Hydrolases/metabolism ; Proteomics
    Chemical Substances Lipoproteins, HDL ; Peptide Hydrolases (EC 3.4.-)
    Language English
    Publishing date 2007-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI26206
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Coenzyme Q10 supplementation improves cholesterol efflux capacity and antiinflammatory properties of high-density lipoprotein in Chinese adults with dyslipidemia.

    Zou, Jinchao / Tian, Zezhong / Zhao, Yimin / Qiu, Xiaofen / Mao, Yuheng / Li, Kongyao / Shi, Yilin / Zhao, Dan / Liang, Ying / Ji, Qiuhua / Ling, Wenhua / Yang, Yan

    Nutrition (Burbank, Los Angeles County, Calif.)

    2022  Volume 101, Page(s) 111703

    Abstract: ... for 24 wk can significantly improve HDL-mediated CEC and antiinflammatory function of HDL in patients ... density lipoprotein (HDL) function in patients with dyslipidemia. The aim of this study was to explore ... the effects of CoQ10 supplementation on HDL function in people with dyslipidemia.: Methods: A 24-wk ...

    Abstract Objectives: Coenzyme Q10 (CoQ10) had shown promising effects in improving the lipid and glycemic profile in dyslipidemic individuals in our previous work, but little is known about how it affects high-density lipoprotein (HDL) function in patients with dyslipidemia. The aim of this study was to explore the effects of CoQ10 supplementation on HDL function in people with dyslipidemia.
    Methods: A 24-wk, randomized, double-blind, placebo-controlled trial was conducted in 101 people with dyslipidemia. All patients were randomized into the CoQ10 group (120 mg/d, n = 51) or the placebo group (n = 50). High-density lipoprotein-mediated cholesterol efflux capacity (CEC), HDL inflammatory index (HII), and HDL intrinsic oxidation were measured at baseline, 12 wk, and 24 wk.
    Results: CoQ10 supplementation for 24 wk significantly improved HDL-mediated CEC (mean change, 1.21±2.44 versus -0.12±2.94; P = 0.014) and reduced HII (mean change, -0.32±0.58 versus -0.05±0.49, P = 0.014) compared with placebo. However, there was no significant difference in the effect of CoQ10 on HDL intrinsic oxidation between the two groups after 24 wk (P = 0.290). A positive correlation was found between the changes in CEC and HDL cholesterol in the CoQ10 group (r, 0.30; P = 0.032). Furthermore, we also found that the improved HDL functions were more obvious in elderly, female, or non-obese individuals, which indicated a specific population that benefits most from CoQ10 intervention.
    Conclusions: This study suggested that supplementation of CoQ10 for 24 wk can significantly improve HDL-mediated CEC and antiinflammatory function of HDL in patients with dyslipidemia.
    MeSH term(s) Adult ; Aged ; China ; Cholesterol, HDL ; Dietary Supplements ; Double-Blind Method ; Dyslipidemias/drug therapy ; Female ; Humans ; Lipoproteins, HDL ; Ubiquinone/analogs & derivatives ; Ubiquinone/pharmacology ; Ubiquinone/therapeutic use
    Chemical Substances Cholesterol, HDL ; Lipoproteins, HDL ; Ubiquinone (1339-63-5) ; coenzyme Q10 (EJ27X76M46)
    Language English
    Publishing date 2022-04-22
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 639259-3
    ISSN 1873-1244 ; 0899-9007
    ISSN (online) 1873-1244
    ISSN 0899-9007
    DOI 10.1016/j.nut.2022.111703
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: The effects of atorvastatin on antioxidant/antiinflammatory properties of HDLs in hypercholesterolemics.

    Akalin Çiftçi, Gülşen / Ertorun, İpek / Akalin, Aysen / Alataş, İbrahim Özkan / Musmul, Ahmet

    Turkish journal of medical sciences

    2015  Volume 45, Issue 2, Page(s) 345–351

    Abstract: ... treatment, glucose, lipid parameters, and antioxidant/antiinflammatory HDL levels were also measured ... proinflammatory HDL levels. Atorvastatin is a beneficial pharmacological modulator of impaired antiinflammatory ... pathway, and oxidative stress markers, but functions of high-density lipoprotein (HDL) were not well ...

    Abstract Background/aim: Hypercholesterolemia is characterized by changes in lipid profile, nitric oxide pathway, and oxidative stress markers, but functions of high-density lipoprotein (HDL) were not well established in hypercholesterolemic subjects treated with atorvastatin. In this study, we aimed to evaluate effects of atorvastatin treatment on functionality of HDL, oxidative stress, and endothelial functions in hypercholesterolemic subjects.
    Materials and methods: Thirty patients (20 females, 10 males) aged from 40 to 60 years and diagnosed as hypercholesterolemic were included. Patients were treated with 10 mg/day atorvastatin for 3 months. Markers of endothelial functions, namely asymmetric dimethylarginine (ADMA), homocysteine, and nitric oxide (NO), and markers of oxidative status, namely malondialdehyde (MDA), antioxidant potential (AOP), paraoxonase 1 (PON1), and arylesterase, were measured. Before and after atorvastatin treatment, glucose, lipid parameters, and antioxidant/antiinflammatory HDL levels were also measured.
    Results: ADMA and homocysteine levels were decreased whereas NO levels were increased with atorvastatin therapy. MDA levels were decreased but AOP, PON1, and arylesterase levels and antinflammatory characteristics of HDLs were increased. Furthermore, lipid profiles of the patients improved with atorvastatin therapy.
    Conclusion: Hypercholesterolemia is a cause of oxidative stress, endothelial dysfunction, and proinflammatory HDL levels. Atorvastatin is a beneficial pharmacological modulator of impaired antiinflammatory HDL-C levels, endothelial functions, and oxidative status against atherosclerosis indicating pleiotropic effects of statins.
    MeSH term(s) Adult ; Anticholesteremic Agents/administration & dosage ; Arginine/analogs & derivatives ; Arginine/blood ; Atorvastatin ; Drug Monitoring ; Female ; Heptanoic Acids/administration & dosage ; Humans ; Hypercholesterolemia/blood ; Hypercholesterolemia/drug therapy ; Hypercholesterolemia/physiopathology ; Inflammation/blood ; Inflammation/drug therapy ; Lipoproteins, HDL/metabolism ; Male ; Malondialdehyde/blood ; Middle Aged ; Nitric Oxide/blood ; Oxidative Stress/drug effects ; Pyrroles/administration & dosage ; Treatment Outcome
    Chemical Substances Anticholesteremic Agents ; Heptanoic Acids ; Lipoproteins, HDL ; Pyrroles ; Nitric Oxide (31C4KY9ESH) ; Malondialdehyde (4Y8F71G49Q) ; N,N-dimethylarginine (63CV1GEK3Y) ; Arginine (94ZLA3W45F) ; Atorvastatin (A0JWA85V8F)
    Language English
    Publishing date 2015-06-17
    Publishing country Turkey
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1183461-4
    ISSN 1303-6165 ; 1300-0144
    ISSN (online) 1303-6165
    ISSN 1300-0144
    DOI 10.3906/sag-1311-91
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults.

    Spitsin, Sergei / Tebas, Pablo / Barrett, Jeffrey S / Pappa, Vasiliki / Kim, Deborah / Taylor, Deanne / Evans, Dwight L / Douglas, Steven D

    JCI insight

    2017  Volume 2, Issue 19

    Abstract: ... antiinflammatory properties of aprepitant in HIV-positive individuals receiving cART.: Methods: We conducted ... Conclusions: Aprepitant is safe and well tolerated. The antiinflammatory properties of aprepitant make ... CD163 was observed. Aprepitant treatment was associated with a moderate increases in total and HDL ...

    Abstract Background: HIV-infected individuals, even well controlled with combined antiretroviral therapy (cART), have systemic inflammation and comorbidities. Substance P (SP) is an undecapeptide, which mediates neurotransmission and inflammation through its cognate neurokinin 1 receptor (NK1R). Plasma SP levels are elevated in HIV-infected individuals. The FDA-approved antiemetic aprepitant, an NK1R antagonist, has anti-HIV effects and antiinflammatory actions. We evaluated the safety, pharmacokinetics, and antiinflammatory properties of aprepitant in HIV-positive individuals receiving cART.
    Methods: We conducted a phase 1B study of 12 HIV-positive individuals on a ritonavir-containing regimen (HIV viral load less than 40 copies/ml and CD4 > 400 cells/μl). Participants received open-label aprepitant 375 mg per day for 28 days and were followed for an additional 30 days. Changes in plasma levels of proinflammatory markers were assessed using flow cytometry, ELISA, luminex, and SOMAscan assays.
    Results: The mean peak aprepitant plasma concentration was 30.7 ± 15.3 μg/ml at day 14 and 23.3 ± 12.3 μg/ml at day 28. Aprepitant treatment resulted in decreased plasma SP levels and affected 176 plasma proteins (56 after FDR) and several metabolic pathways, including inflammation and lipid metabolism. No change in soluble CD163 was observed. Aprepitant treatment was associated with a moderate increases in total and HDL cholesterol and affected select hematologic and metabolic markers, which returned to baseline levels 30 days after aprepitant treatment was stopped. There were 12 mild and 10 moderate adverse events (AE).
    Conclusions: Aprepitant is safe and well tolerated. The antiinflammatory properties of aprepitant make it a possible adjunctive therapy for comorbid conditions associated with HIV infection.
    Trial registration: ClinicalTrials.gov (NCT02154360).
    Funding: This research was funded by NIH UO1 MH090325, P30 MH097488, and PO1 MH105303.
    MeSH term(s) Adult ; Aged ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/blood ; Anti-HIV Agents/therapeutic use ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/blood ; Anti-Inflammatory Agents/therapeutic use ; Aprepitant/administration & dosage ; Aprepitant/adverse effects ; Aprepitant/blood ; Aprepitant/therapeutic use ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; HIV Infections/blood ; HIV Infections/drug therapy ; HIV Infections/virology ; Humans ; Inflammation Mediators/metabolism ; Male ; Middle Aged ; Ritonavir/therapeutic use ; Viral Load
    Chemical Substances Anti-HIV Agents ; Anti-Inflammatory Agents ; Inflammation Mediators ; Aprepitant (1NF15YR6UY) ; Ritonavir (O3J8G9O825)
    Language English
    Publishing date 2017-10-05
    Publishing country United States
    Document type Clinical Trial, Phase I ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.95893
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

    Nobécourt, Estelle / Tabet, Fatiha / Lambert, Gilles / Puranik, Rajesh / Bao, Shisan / Yan, Ling / Davies, Michael J / Brown, Bronwyn E / Jenkins, Alicia J / Dusting, Gregory J / Bonnet, David J / Curtiss, Linda K / Barter, Philip J / Rye, Kerry-Anne

    Arteriosclerosis, thrombosis, and vascular biology

    2010  Volume 30, Issue 4, Page(s) 766–772

    Abstract: ... on the antiinflammatory properties of apolipoprotein (apo) A-I.: Methods and results: Rabbits were infused with saline ... antiinflammatory properties of nonenzymatically glycated apoA-I were attributed to a reduced ability to inhibit ... glycation impairs the antiinflammatory properties of apoA-I. ...

    Abstract Objective: The goal of this study was to investigate the effects of nonenzymatic glycation on the antiinflammatory properties of apolipoprotein (apo) A-I.
    Methods and results: Rabbits were infused with saline, lipid-free apoA-I from normal subjects (apoA-I(N)), lipid-free apoA-I nonenzymatically glycated by incubation with methylglyoxal (apoA-I(Glyc in vitro)), nonenzymatically glycated lipid-free apoA-I from subjects with diabetes (apoA-I(Glyc in vivo)), discoidal reconstituted high-density lipoproteins (rHDL) containing phosphatidylcholine and apoA-I(N), (A-I(N))rHDL, or apoA-I(Glyc in vitro), (A-I(Glyc in vitro))rHDL. At 24 hours postinfusion, acute vascular inflammation was induced by inserting a nonocclusive, periarterial carotid collar. The animals were euthanized 24 hours after the insertion of the collar. The collars caused intima/media neutrophil infiltration and increased endothelial expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1). ApoA-I(N) infusion decreased neutrophil infiltration and VCAM-1 and ICAM-1 expression by 89%, 90%, and 66%, respectively. The apoA-I(Glyc in vitro) infusion decreased neutrophil infiltration by 53% but did not reduce VCAM-1 or ICAM-1 expression. ApoA-I(Glyc in vivo) did not inhibit neutrophil infiltration or adhesion molecule expression. (A-I(Glyc in vitro))rHDL also inhibited vascular inflammation less effectively than (A-I(N))rHDL. The reduced antiinflammatory properties of nonenzymatically glycated apoA-I were attributed to a reduced ability to inhibit nuclear factor-kappaB activation and reactive oxygen species formation.
    Conclusions: Nonenzymatic glycation impairs the antiinflammatory properties of apoA-I.
    MeSH term(s) Active Transport, Cell Nucleus ; Animals ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/metabolism ; Apolipoprotein A-I/administration & dosage ; Apolipoprotein A-I/metabolism ; Carotid Arteries/immunology ; Carotid Arteries/metabolism ; Carotid Artery Injuries/immunology ; Carotid Artery Injuries/metabolism ; Carotid Artery Injuries/prevention & control ; Diabetes Mellitus, Type 2/immunology ; Diabetes Mellitus, Type 2/metabolism ; Diabetic Angiopathies/immunology ; Diabetic Angiopathies/metabolism ; Disease Models, Animal ; Glycosylation ; Humans ; I-kappa B Proteins/metabolism ; Inflammation/immunology ; Inflammation/metabolism ; Inflammation/prevention & control ; Infusions, Parenteral ; Intercellular Adhesion Molecule-1/metabolism ; Lipoproteins, HDL/metabolism ; NF-KappaB Inhibitor alpha ; NF-kappa B/metabolism ; Neutrophil Infiltration ; Phosphatidylcholines/metabolism ; Phosphorylation ; Protein Processing, Post-Translational ; Pyruvaldehyde/metabolism ; Rabbits ; Reactive Oxygen Species/metabolism ; Time Factors ; Vascular Cell Adhesion Molecule-1/metabolism
    Chemical Substances APOA1 protein, human ; Anti-Inflammatory Agents ; Apolipoprotein A-I ; I-kappa B Proteins ; Lipoproteins, HDL ; NF-kappa B ; NFKBIA protein, human ; Phosphatidylcholines ; Reactive Oxygen Species ; Vascular Cell Adhesion Molecule-1 ; Intercellular Adhesion Molecule-1 (126547-89-5) ; NF-KappaB Inhibitor alpha (139874-52-5) ; Pyruvaldehyde (722KLD7415)
    Language English
    Publishing date 2010-01-28
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.109.201715
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top